Parkman Healthcare Partners
Latest statistics and disclosures from Parkman Healthcare Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are THC, UTHR, BSX, COO, SDGR, and represent 17.72% of Parkman Healthcare Partners's stock portfolio.
- Added to shares of these 10 stocks: COO (+$29M), LLY (+$25M), FTRE (+$17M), SDGR (+$17M), ABT (+$14M), SNDX (+$14M), QGEN (+$14M), OSCR (+$12M), INSP (+$12M), SILK (+$11M).
- Started 33 new stock positions in ABT, NKTX, VYNE, FOLD, EPIX, TEVA, CYTK, OSCR, NVCR, LIVN.
- Reduced shares in these 10 stocks: Cooper Companies (-$21M), DXCM (-$13M), BDX (-$13M), BSX (-$12M), , HUM (-$10M), Karuna Therapeutics Ord (-$8.7M), ZBH (-$8.0M), KROS (-$8.0M), CRL (-$7.2M).
- Sold out of its positions in ANIP, ACAD, ACRS, AFIB, AKRO, Ambrx Biopharma, AMGN, ASLN, BDTX, BBIO.
- Parkman Healthcare Partners was a net buyer of stock by $135M.
- Parkman Healthcare Partners has $815M in assets under management (AUM), dropping by 49.34%.
- Central Index Key (CIK): 0001777015
Tip: Access up to 7 years of quarterly data
Positions held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 99 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tenet Healthcare Corp Com New (THC) | 3.7 | $30M | +25% | 284k | 105.11 |
|
| United Therapeutics Corporation (UTHR) | 3.6 | $29M | -7% | 128k | 229.72 |
|
| Boston Scientific Corporation (BSX) | 3.6 | $29M | -28% | 426k | 68.49 |
|
| Cooper Cos (COO) | 3.6 | $29M | NEW | 285k | 101.46 |
|
| Schrodinger (SDGR) | 3.3 | $27M | +171% | 1.0M | 27.00 |
|
| Eli Lilly & Co. (LLY) | 3.1 | $25M | NEW | 32k | 777.96 |
|
| Dex (DXCM) | 2.9 | $24M | -35% | 172k | 138.70 |
|
| AmerisourceBergen (COR) | 2.9 | $24M | 98k | 242.99 |
|
|
| Rxsight (RXST) | 2.6 | $21M | +8% | 412k | 51.58 |
|
| Syndax Pharmaceuticals (SNDX) | 2.3 | $19M | +269% | 785k | 23.80 |
|
| Neurocrine Biosciences (NBIX) | 2.2 | $18M | +57% | 132k | 137.92 |
|
| Inspire Med Sys (INSP) | 2.1 | $17M | +201% | 81k | 214.79 |
|
| Fortrea Hldgs Common Stock (FTRE) | 2.1 | $17M | NEW | 428k | 40.14 |
|
| Insulet Corporation (PODD) | 1.9 | $16M | +116% | 91k | 171.40 |
|
| Silk Road Medical Inc Common (SILK) | 1.9 | $16M | +240% | 849k | 18.32 |
|
| Longboard Pharmaceuticals In (LBPH) | 1.8 | $15M | +94% | 693k | 21.60 |
|
| Abbott Laboratories (ABT) | 1.7 | $14M | NEW | 122k | 113.66 |
|
| Qiagen Nv Shs New (QGEN) | 1.7 | $14M | NEW | 314k | 42.99 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.6 | $13M | +327% | 524k | 24.90 |
|
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 1.6 | $13M | +26% | 646k | 19.73 |
|
| Applied Therapeutics (APLT) | 1.5 | $13M | +5% | 1.9M | 6.80 |
|
| Oscar Health Cl A (OSCR) | 1.5 | $12M | NEW | 831k | 14.87 |
|
| Edgewise Therapeutics (EWTX) | 1.5 | $12M | +38% | 654k | 18.24 |
|
| Keros Therapeutics (KROS) | 1.4 | $12M | -40% | 178k | 66.20 |
|
| Hca Holdings (HCA) | 1.4 | $12M | -37% | 35k | 333.53 |
|
| Deciphera Pharmaceuticals (DCPH) | 1.4 | $12M | +22% | 729k | 15.73 |
|
| Day One Biopharmaceuticals I (DAWN) | 1.4 | $11M | +48% | 692k | 16.52 |
|
| Becton, Dickinson and (BDX) | 1.4 | $11M | -53% | 46k | 247.45 |
|
| Mannkind Corp Com New (MNKD) | 1.3 | $11M | +16% | 2.4M | 4.53 |
|
| Arcellx Common Stock (ACLX) | 1.3 | $11M | -23% | 157k | 69.55 |
|
| Vaxcyte (PCVX) | 1.3 | $10M | -37% | 150k | 68.31 |
|
| Sutro Biopharma (STRO) | 1.2 | $10M | +51% | 1.8M | 5.65 |
|
| Xenon Pharmaceuticals (XENE) | 1.2 | $9.6M | +3% | 224k | 43.05 |
|
| Thermo Fisher Scientific (TMO) | 1.1 | $9.1M | 16k | 581.21 |
|
|
| Verona Pharma Sponsored Ads (VRNA) | 1.0 | $8.5M | +26% | 530k | 16.09 |
|
| Castle Biosciences (CSTL) | 1.0 | $8.1M | +63% | 367k | 22.15 |
|
| Livanova SHS (LIVN) | 1.0 | $8.1M | NEW | 145k | 55.94 |
|
| Anthem (ELV) | 1.0 | $7.9M | NEW | 15k | 518.54 |
|
| Haemonetics Corporation (HAE) | 1.0 | $7.8M | +2% | 91k | 85.35 |
|
| Travere Therapeutics (TVTX) | 0.9 | $7.5M | +67% | 968k | 7.71 |
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.9 | $7.4M | +750% | 850k | 8.71 |
|
| Disc Medicine (IRON) | 0.8 | $6.7M | +106% | 108k | 62.26 |
|
| Ventyx Biosciences (VTYX) | 0.8 | $6.6M | NEW | 1.2M | 5.50 |
|
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.8 | $6.5M | NEW | 388k | 16.89 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.8 | $6.4M | NEW | 454k | 14.11 |
|
| Ionis Pharmaceuticals (IONS) | 0.8 | $6.1M | -11% | 142k | 43.35 |
|
| CVRX (CVRX) | 0.7 | $6.0M | +49% | 332k | 18.21 |
|
| Inari Medical Ord (NARI) | 0.7 | $6.0M | NEW | 125k | 47.98 |
|
| Veracyte (VCYT) | 0.7 | $5.6M | +12% | 254k | 22.16 |
|
| Silence Therapeutics Ads (SLN) | 0.6 | $5.3M | +26% | 245k | 21.60 |
|
| Arvinas Ord (ARVN) | 0.6 | $5.2M | +20% | 125k | 41.28 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $5.1M | +89% | 101k | 50.23 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.6 | $4.9M | +26% | 260k | 18.88 |
|
| Performant Finl (PFMT) | 0.6 | $4.9M | +27% | 1.7M | 2.94 |
|
| Intra Cellular Therapies (ITCI) | 0.6 | $4.8M | NEW | 70k | 69.20 |
|
| Charles River Laboratories (CRL) | 0.6 | $4.8M | -59% | 18k | 270.95 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.6 | $4.7M | -19% | 200k | 23.65 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.6 | $4.7M | 101k | 46.81 |
|
|
| Alphatec Hldgs Com New (ATEC) | 0.6 | $4.6M | NEW | 337k | 13.79 |
|
| D Fluidigm Corp Del (LAB) | 0.6 | $4.5M | +234% | 1.7M | 2.71 |
|
| Centene Corporation (CNC) | 0.5 | $4.4M | NEW | 56k | 78.48 |
|
| Augmedix (AUGX) | 0.5 | $4.4M | +183% | 1.1M | 4.09 |
|
| Akoya Biosciences (AKYA) | 0.5 | $4.3M | +74% | 917k | 4.69 |
|
| Quanterix Ord (QTRX) | 0.5 | $4.1M | +128% | 176k | 23.56 |
|
| Lyra Therapeutics (LYRA) | 0.5 | $4.0M | +2% | 642k | 6.22 |
|
| Nurix Therapeutics (NRIX) | 0.5 | $3.7M | NEW | 250k | 14.70 |
|
| Merus N V (MRUS) | 0.4 | $3.6M | -38% | 80k | 45.03 |
|
| Nuvalent Inc-a (NUVL) | 0.4 | $3.6M | NEW | 48k | 75.09 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.4 | $3.3M | NEW | 267k | 12.41 |
|
| Elanco Animal Health (ELAN) | 0.4 | $3.3M | NEW | 201k | 16.28 |
|
| Esperion Therapeutics (ESPR) | 0.4 | $3.1M | -42% | 1.1M | 2.68 |
|
| Cullinan Oncology (CGEM) | 0.4 | $3.0M | -59% | 178k | 17.04 |
|
| Ideaya Biosciences (IDYA) | 0.4 | $2.9M | -50% | 66k | 43.88 |
|
| Urogen Pharma (URGN) | 0.3 | $2.8M | +26% | 184k | 15.00 |
|
| Nkarta (NKTX) | 0.3 | $2.7M | NEW | 252k | 10.81 |
|
| Amicus Therapeutics (FOLD) | 0.3 | $2.7M | NEW | 227k | 11.78 |
|
| Insmed Com Par $.01 (INSM) | 0.3 | $2.5M | -25% | 93k | 27.13 |
|
| Si-bone (SIBN) | 0.3 | $2.5M | 153k | 16.37 |
|
|
| Annexon (ANNX) | 0.3 | $2.5M | NEW | 347k | 7.17 |
|
| Viking Therapeutics (VKTX) | 0.3 | $2.5M | NEW | 30k | 82.00 |
|
| Tg Therapeutics (TGTX) | 0.3 | $2.4M | -25% | 155k | 15.21 |
|
| Acumen Pharmaceuticals (ABOS) | 0.3 | $2.3M | +15% | 577k | 4.05 |
|
| Vyne Therapeutics (VYNE) | 0.3 | $2.1M | NEW | 697k | 3.07 |
|
| Essa Pharma Com New (EPIX) | 0.3 | $2.1M | NEW | 252k | 8.49 |
|
| 89bio (ETNB) | 0.3 | $2.1M | -50% | 180k | 11.64 |
|
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.2 | $1.9M | NEW | 504k | 3.78 |
|
| Peregrine Pharmaceuticals (CDMO) | 0.2 | $1.8M | +45% | 270k | 6.70 |
|
| Inozyme Pharma (INZY) | 0.2 | $1.7M | +26% | 223k | 7.66 |
|
| Ardelyx (ARDX) | 0.2 | $1.5M | NEW | 200k | 7.30 |
|
| Cytokinetics Com New (CYTK) | 0.2 | $1.4M | NEW | 20k | 70.11 |
|
| X4 Pharmaceuticals (XFOR) | 0.1 | $1.1M | 805k | 1.39 |
|
|
| Sophia Genetics Sa Ordinary Shares (SOPH) | 0.1 | $1.0M | NEW | 210k | 4.93 |
|
| Butterfly Network Com Cl A (BFLY) | 0.1 | $810k | NEW | 750k | 1.08 |
|
| Alpha Teknova (TKNO) | 0.1 | $785k | +26% | 296k | 2.65 |
|
| Novocure Ord Shs (NVCR) | 0.1 | $782k | NEW | 50k | 15.63 |
|
| Eton Pharmaceuticals (ETON) | 0.1 | $747k | +20% | 199k | 3.75 |
|
| Tela Bio (TELA) | 0.1 | $554k | -41% | 98k | 5.67 |
|
| Third Harmonic Bio (THRD) | 0.0 | $378k | NEW | 40k | 9.44 |
|
| Xeris Pharmaceuticals (XERS) | 0.0 | $223k | NEW | 101k | 2.21 |
|
Past Filings by Parkman Healthcare Partners
SEC 13F filings are viewable for Parkman Healthcare Partners going back to 2019
- Parkman Healthcare Partners 2024 Q1 filed May 15, 2024
- Parkman Healthcare Partners 2023 Q3 filed Nov. 14, 2023
- Parkman Healthcare Partners 2023 Q2 filed Aug. 11, 2023
- Parkman Healthcare Partners 2023 Q1 filed May 12, 2023
- Parkman Healthcare Partners 2022 Q4 filed Feb. 13, 2023
- Parkman Healthcare Partners 2022 Q3 filed Nov. 14, 2022
- Parkman Healthcare Partners 2022 Q2 filed Aug. 12, 2022
- Parkman Healthcare Partners 2022 Q1 filed May 13, 2022
- Parkman Healthcare Partners 2021 Q4 filed Feb. 11, 2022
- Parkman Healthcare Partners 2021 Q3 filed Nov. 12, 2021
- Parkman Healthcare Partners 2021 Q2 filed Aug. 13, 2021
- Parkman Healthcare Partners 2021 Q1 filed May 14, 2021
- Parkman Healthcare Partners 2020 Q4 filed Feb. 12, 2021
- Parkman Healthcare Partners 2020 Q3 filed Nov. 13, 2020
- Parkman Healthcare Partners 2020 Q2 filed Aug. 13, 2020
- Parkman Healthcare Partners 2020 Q1 filed May 15, 2020